ENTITY
Bionote

Bionote (377740 KS)

37
Analysis
Health Care • South Korea
Bionote, Inc. manufactures and distributes animal diseases diagnostic kits and equipment. The Company provides immunochemical diagnosis, point of care, enzyme immunoassay, fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, enzyme linked immunosorbent assay, and other related services. Bionote markets its products worldwide.
more
•03 Feb 2023 10:22

New Ruipeng Pet Group Pre-IPO - The Negative - Loss-Making and Cash Burn Could Dampen Ambitions

New Ruipeng Pet Group (RPET US) is looking to raise at least US$100m in its upcoming US IPO. In this note, we will talk about the not-so-positive...

Logo
673 Views
Share
•02 Feb 2023 14:13

New Ruipeng Pet Group Pre-IPO - The Positives - Compelling Growth Story Reflected in Sales Growth

New Ruipeng Pet Group (RPET US) is looking to raise at least US$100m in its upcoming US IPO. Ruipeng is a pet services platform, primarily offering...

Logo
547 Views
Share
bullish•Alibaba
•08 Jan 2023 07:25

ECM Weekly (8th Jan 2022) - Sinohytec, Beauty Farm, Sula, Kfin, Bionote, Meidong, CIFI, Jinxin Fert

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
681 Views
Share
bearish•Bionote
•21 Dec 2022 11:19

Bionote IPO Trading - Weakest Demand Even After Cutting Price and Size

Bionote (377740 KS) raised US$72.2m in its Korean IPO. In this note, we will talk about the demand for the deal and other trading dynamics.

Logo
852 Views
Share
bullish•Bionote
•13 Dec 2022 04:15

Bionote: IPO Price Reduced Significantly & Bookbuilding Results

Bionote slashed its IPO price to 9,000 won, a 50% lower than the low end of IPO range. Our base case valuation is lowered to 12,741 won per share,...

Logo
522 Views
Share
x